CompanyCPHINYSEHainan Province, F4

China Pharma Holdings, Inc.

China Pharma Holdings develops and manufactures specialty pharmaceuticals for cardiovascular, CNS, infectious, and digestive diseases in China.

SEC EDGAR ClinicalTrials.gov chinapharmaholdings.com

10-QAug 14Latest SEC filing, period to Jun 30

Jul 23Latest story

July 2026

China Pharma Holdings prices $5 million registered direct offering at $2.00 per share

Jul 23FinancingChina Pharma Holdings, Inc.